Sonoma Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	2.56	5.37	3.13	3.82	7.4	4.22
Cash & Short-Term Investments	2.56	5.37	3.13	3.82	7.4	4.22
Cash Growth	-51.09%	71.80%	-18.12%	-48.35%	75.26%	14.33%
Accounts Receivable	2.38	2.23	2.9	2.57	2.41	2.81
Other Receivables	0.15	0.21	0.26	0.24	0.22	0.21
Receivables	2.53	2.44	3.16	2.81	2.63	3.02
Inventory	3.7	2.92	2.72	2.86	2.66	2.53
Prepaid Expenses	3.35	1.92	3.54	4.31	3.75	3.22
Total Current Assets	12.15	12.65	12.55	13.8	16.43	12.98
Property, Plant & Equipment	0.96	0.31	0.65	0.91	0.88	1.13
Long-Term Deferred Tax Assets	0.46	0.59	1.15	0.95	0.83	-
Other Long-Term Assets	0.06	0.15	0.4	0.58	0.71	0.88
Total Assets	13.62	13.69	14.74	16.23	18.85	14.99
Accounts Payable	1.65	0.95	0.61	0.84	1.64	1.77
Accrued Expenses	2.11	1.74	1.42	1.46	1.06	0.79
Short-Term Debt	-	0.22	0.32	0.43	0.69	0.6
Current Portion of Long-Term Debt	-	-	-	-	0.12	-
Current Portion of Leases	0.15	0.06	0.2	0.26	0.25	0.24
Current Unearned Revenue	0.31	0.64	0.48	0.16	1.28	0.32
Other Current Liabilities	-	0.49	0.69	0.57	0.78	0.37
Total Current Liabilities	4.22	4.1	3.72	3.72	5.82	4.08
Long-Term Debt	-	-	-	-	-	1.31
Long-Term Leases	0.51	0.03	0.09	0.16	0.31	0.53
Long-Term Unearned Revenue	-	0.02	0.09	0.14	0.18	0.23
Other Long-Term Liabilities	5.47	5.14	4.71	4.24	3.84	3.48
Total Liabilities	10.19	9.28	8.6	8.25	10.15	9.62
Common Stock	-	-	-	0.01	0	0
Additional Paid-In Capital	207.02	206.59	203.21	200.9	197.37	189.22
Retained Earnings	-200.4	-197.81	-194.35	-189.51	-184.36	-179.28
Comprehensive Income & Other	-3.19	-4.38	-2.72	-3.42	-4.31	-4.58
Shareholders' Equity	3.43	4.41	6.14	7.98	8.7	5.36
Total Liabilities & Equity	13.62	13.69	14.74	16.23	18.85	14.99
Total Debt	0.66	0.31	0.61	0.85	1.37	2.68
Net Cash (Debt)	1.91	5.07	2.52	2.97	6.03	1.55
Net Cash Growth	-62.75%	101.15%	-15.18%	-50.72%	290.23%	-45.62%
Net Cash Per Share	1.15	4.08	5.54	17.51	45.45	15.48
Filing Date Shares Outstanding	1.73	1.64	0.94	0.25	0.16	0.1
Total Common Shares Outstanding	1.73	1.63	0.78	0.25	0.16	0.1
Working Capital	7.93	8.55	8.83	10.08	10.61	8.91
Book Value Per Share	1.98	2.70	7.86	32.34	56.09	51.25
Tangible Book Value	3.43	4.41	6.14	7.98	8.7	5.36
Tangible Book Value Per Share	1.98	2.70	7.86	32.34	56.09	51.25
Machinery	-	1.81	2.14	1.95	1.53	1.35
Leasehold Improvements	-	0.49	0.61	0.55	0.5	0.49

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q